(Q40558263)

21 September 2017

1 reference

title

Bone marrow transplantation for acute lymphoblastic leukaemia (English)

1 reference

21 September 2017

1 reference

Barrett AJ

1

1 reference

21 September 2017

publication date

1 June 1994

1 reference

Best Practice and Research: Clinical Haematology

21 September 2017

published in

1 reference

21 September 2017

volume

7

1 reference

21 September 2017

issue

2

1 reference

21 September 2017

page(s)

377-401

1 reference

How should acute lymphoblastic leukaemia relapsing after bone-marrow transplantation be treated?

21 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980209-4

7 January 2021

Prediction and prevention of relapse of acute lymphoblastic leukaemia after bone marrow transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980209-4

7 January 2021

Second transplants for leukaemic relapse after bone marrow transplantation: high early mortality but favourable effect of chronic GVHD on continued remission. A report by the EBMT Leukaemia Working Party

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980209-4

7 January 2021

Marrow transplantation from related donors other than HLA-identical siblings

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980209-4

7 January 2021

Marrow transplantation from HLA-matched unrelated donors for treatment of hematologic malignancies

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980209-4

7 January 2021

Allogeneic bone marrow transplantation for acute lymphoblastic leukemia during first complete remission

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980209-4

7 January 2021

Allogeneic bone marrow transplantation for children with acute lymphoblastic leukemia in first remission: a cooperative study of the Groupe d'Etude de la Greffe de Moelle Osseuse.

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980209-4

7 January 2021

Changing Trends in Allogeneic Bone Marrow Transplantation for Leukemia in the 1980s

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980209-4

7 January 2021

Allogeneic bone marrow transplantation after hyperfractionated total-body irradiation and cyclophosphamide in children with acute leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980209-4

7 January 2021

Which treatment for childhood acute lymphoblastic leukaemia in second remission?

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980209-4

7 January 2021

Treatment of childhood acute lymphoblastic leukaemia: present issues and future prospects

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980209-4

7 January 2021

Bone-marrow transplantation has a limited role in prolonging second marrow remission in childhood lymphoblastic leukaemia

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980209-4

7 January 2021

Bone marrow transplantation for high-risk childhood lymphoblastic leukaemia in first remission: experience in MRC UKALL X

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980209-4

7 January 2021

Allogeneic bone marrow transplantation with related donors other than HLA MLC-matched siblings, and the use of antithymocyte globulin, prednisone, and methotrexate for prophylaxis of graft-versus-host disease

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980209-4

7 January 2021

Treatment of relapsed or refractory adult acute lymphocytic leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980209-4

7 January 2021

Treating acute lymphoblastic leukaemia after relapse: bone marrow transplantation or not?

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980209-4

7 January 2021

BONE-MARROW TRANSPLANTATION IN HIGH-RISK ACUTE LYMPHOBLASTIC LEUKAEMIA IN FIRST AND SECOND REMISSION

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980209-4

7 January 2021

Chemotherapy compared with bone marrow transplantation for adults with acute lymphoblastic leukemia in first remission

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980209-4

7 January 2021

The use of DNA probes to monitor minimal residual disease in childhood acute lymphoblastic leukaemia

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980209-4

7 January 2021

Analysis of 462 transplantations from unrelated donors facilitated by the National Marrow Donor Program

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980209-4

7 January 2021

Comparison of autologous and allogeneic bone marrow transplantation for treatment of high-risk refractory acute lymphoblastic leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980209-4

7 January 2021

Bone marrow transplantation for high-risk childhood lymphoblastic leukaemia

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980209-4

7 January 2021

Impact of T-cell depletion on outcome of allogeneic bone-marrow transplantation for standard-risk leukaemias

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980209-4

7 January 2021

Detection of chimeric BCR-ABL genes in acute lymphoblastic leukaemia by the polymerase chain reaction.

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980209-4

7 January 2021

Second neoplasms after acute lymphoblastic leukemia in childhood.

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980209-4

7 January 2021

Follow-up of residual disease (MRD) in B lineage acute leukaemias using a simplified PCR strategy: evolution of MRD rather than its detection is correlated with clinical outcome

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980209-4

7 January 2021

The significance of detection of minimal residual disease in childhood acute lymphoblastic leukaemia.

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980209-4

7 January 2021

MISMATCHED FAMILY DONORS FOR BONE-MARROW TRANSPLANTATION AS TREATMENT FOR ACUTE LEUKAEMIA

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980209-4

7 January 2021

A comparative study of combination chemotherapy versus marrow transplant in first remission in adult acute lymphoblastic leukaemia

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980209-4

7 January 2021

Intensive retreatment of childhood acute lymphoblastic leukemia in first bone marrow relapse. A Pediatric Oncology Group Study

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980209-4

7 January 2021

Improved outcome in childhood acute lymphoblastic leukaemia with reinforced early treatment and rotational combination chemotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980209-4

7 January 2021

Marrow transplantation for acute nonlymphoblastic leukemic in first remission using fractionated or single-dose irradiation

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980209-4

7 January 2021

Allogeneic bone marrow transplantation in adults with acute lymphoblastic leukemia in first complete remission

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980209-4

7 January 2021

Fractionated total body irradiation in marrow transplantation for leukaemia

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980209-4

7 January 2021

Minor histocompatibility antigen H-Y is expressed on human hematopoietic progenitor cells

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980209-4

7 January 2021

Antileukemic effect of chronic graft-versus-host disease: contribution to improved survival after allogeneic marrow transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980209-4

7 January 2021

Allogeneic bone marrow transplantation for acute lymphoblastic leukemia in remission: prolonged survival associated with acute graft-versus-host disease

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980209-4

7 January 2021

Allogeneic bone marrow transplantation for patients with high-risk acute lymphoblastic leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980209-4

7 January 2021

Secondary cancers after bone marrow transplantation for leukemia or aplastic anemia

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980209-4

7 January 2021

Discrimination of human CD4 T cell clones based on their reactivity with antigen-presenting T cells

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980209-4

7 January 2021

Minimal residual disease in childhood B-lineage lymphoblastic leukemia. Persistence of leukemic cells during the first 18 months of treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980209-4

7 January 2021

10.1016/S0950-3536(05)80209-4

Identifiers

DOI

1 reference

21 September 2017

1 reference